JSM Activity #25

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2002 Program page

Activity ID:  25
! Measuring Dementia: An Emerging Challenge
Date / Time / Room Sponsor Type
4:00 PM - 5:50 PM
Room: H-Gramercy Suite A
ENAR, Section on Health Policy Statistics*, WNAR Invited
Organizer: C. V. Damaraju, R.W. Johnson Pharmaceutical Research Institute
Chair: C. V. Damaraju, R.W. Johnson Pharmaceutical Research Institute
Discussant: 5:20 PM - Gordon Pledger, R.W. Johnson Pharmaceutical Research Institute    
Floor Discussion 5:40 PM

Measuring various disease indicators, surrogate endpoints and tracking changes in Dementia Research by applying novel rating scales and computerized assessment methods is challenging. The goal of these new methods is to make the 'softer' clinical endpoints more amenable to consistency and standardized across different raters. Also, CT/MRI scan technology is fast emerging as a reliable method to ascertain lesions in the brain for patients with vascular dementia and other cerebrovascular diseases. The speakers in this session will focus on the vast scope of statistical challenge that is inherent in this field with multiple scales, raters, surrogate endpoints/disease markers as well as in connecting to the measurement techniques representing modern technology.
  300071  By:  Sean  Lilienfeld 4:05 PM 08/11/2002
Clinical Endpoints in Dementia Studies: Are They Relevant?

  301712  By:  Kun  Jin 4:30 PM 08/11/2002
Statistical Issues in Alzheimer's Trial

  300073  By:  Ron  Brookmeyer 4:55 PM 08/11/2002
Measuring Dementia from Multidimensional Longitudinal Data

JSM 2002

For information, contact meetings@amstat.org or phone (703) 684-1221.

If you have questions about the Continuing Education program, please contact the Education Department.

Revised March 2002